Search Results
Treating Plaque Psoriasis: IL-17 and IL-23 Inhibitors
Efficacy of IL-23 Inhibitors in Plaque Psoriasis
Use of IL-23 Inhibitors to Treat Plaque Psoriasis
IL-17 Inhibitors for Plaque Psoriasis and IBD
IL-23 Inhibitors and Other Emerging Psoriasis Treatments
lxekizumab Reduces key IL-17 and IL-23 Pathway Genes More Rapidly than Guselkumab | Lam Tsoi, PhD
WCH23: IL-17 vs IL-23 Blockers – Why and When?
IL-17 and IL-23 inhibitors in the treatment of psoriatic arthritis
Psoriasis and beyond: targeting the IL-17 pathway
Laura K. Ferris, MD, PhD - Do IL-17 inhibitors work more quickly than IL-23 inhibitors and what...
Advances in Anti-Cytokine Therapy: New Pathways (IL 12/23, IL17, IL23)
IL-23 Inhibitors in Plaque Psoriasis